Merck et Weizmann (Israël) : accord sans précédent pour la recherche sur le cancer

(l-r) Yeda CEO Amir Naiberg, Vice President for Technology Transfer Prof. Mudi Sheves, Merck Deputy CEO and Vice Chairman of the Executive Board Stefan Oschmann and Merck Executive board member and Healthcare CEO Belén Garijo (l-r) Yeda CEO Amir Naiberg, Vice President for Technology Transfer Prof. Mudi Sheves, Merck Deputy CEO and Vice Chairman of the Executive Board Stefan Oschmann and Merck Executive board member and Healthcare CEO Belén Garijo

Le laboratoire Merk et l’Institut Weizmann des Sciences (Israël) ont signé un nouvel accord de recherche sur le cancer.

Full article on israelscienceinfo.com

Israël Science Info